Anavex Life Sciences
AVXL
#7563
Rank
NZ$0.68 B
Marketcap
NZ$7.62
Share price
-1.12%
Change (1 day)
-41.05%
Change (1 year)

Anavex Life Sciences (AVXL) - Net assets

Net assets on the balance sheet as of June 2025 : NZ$0.15 Billion

According to Anavex Life Sciences 's latest financial reports the company has NZ$0.15 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Anavex Life Sciences - Net assets on balance sheet (from 2005 to 2025)

Net assets by year

Year Net assets Change
2024-09-30$NZ$0.18 B-19.9%
2023-09-30$NZ$0.23 B-6.4%
2022-09-30$NZ$0.25 B15.6%
2021-09-30$NZ$0.21 B431.73%
2020-09-30$NZ$41.12 M26.93%
2019-09-30$NZ$32.39 M-3.86%
2018-09-30$NZ$33.7 M-0.08%
2017-09-30$NZ$33.72 M288.14%
2016-09-30$NZ$8.68 M-56.66%
2015-09-30$NZ$20.04 M8027.5%
2014-09-30$NZ$0.24 M-108.31%
2013-09-30$-NZ$2.97 Million-14.51%
2012-09-30$-NZ$3.48 Million133.33%
2011-09-30$-NZ$1.49 Million-63.1%
2010-09-30$-NZ$4.04 Million-25.37%
2009-09-30$-NZ$5.41 Million58.82%
2008-09-30$-NZ$3.41 Million464.05%
2007-09-30$-NZ$0.61 Million2439.41%
2006-09-30$-NZ$0.03 Million-36.91%
2005-09-30$-NZ$0.04 Million-198.84%
2004-09-30$NZ$0.03 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Ligand Pharmaceuticals
LGND
NZ$1.64 B 944.63%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-NZ$0.68 Billion-526.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
NZ$1.09 B 594.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-NZ$11.06 Million-107.02%๐Ÿ‡บ๐Ÿ‡ธ USA